SMYD3 and neoplasm: Experimental evidences with tumor biopsies and expression analysis of tumor datasets revealed that SMYD3 is over-expressed in various forms of cancer, and that higher SMYD3 levels correlate with a reduced overall survival and worst prognosis [22].